New Delhi: Diagnostic services provider Dr Lal PathLabs Ltd on Thursday said its board of directors has approved a 70 per cent stake acquisition in Gujarat-based SN Genelab for about Rs 168 crore.
The transaction also includes a performance-linked earn-out capped at Rs 31.5 crore, the company said in a regulatory filing.